Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

A synopsis of recent developments in antiglaucoma drugs.

McLaughlin MA, Chiou GC.

J Ocul Pharmacol. 1985 Spring;1(1):101-21. Review.

PMID:
3916848
2.

The role of brimonidine in the treatment of open-angle glaucoma.

Wilensky JT.

Surv Ophthalmol. 1996 Nov;41 Suppl 1:S3-7. Review.

PMID:
8970244
3.

Pharmacotherapies for glaucoma.

Toris CB.

Curr Mol Med. 2010 Dec;10(9):824-40. Review.

PMID:
21091423
4.
5.

The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.

Hoyng PF, Rulo A, Greve E, Watson P, Alm A.

Surv Ophthalmol. 1997 Feb;41 Suppl 2:S93-8. Review.

PMID:
9154283
6.

[Primary open angle glaucoma. Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances].

Lütjen-Drecoll E, Kruse FE.

Ophthalmologe. 2007 Feb;104(2):167-78; quiz 179. Review. German.

PMID:
17242882
7.

Pharmacological management of primary open-angle glaucoma: second-line options and beyond.

Webers CA, Beckers HJ, Nuijts RM, Schouten JS.

Drugs Aging. 2008;25(9):729-59. Review.

PMID:
18729546
8.

Pharmacological therapy for glaucoma: a review.

Hoyng PF, van Beek LM.

Drugs. 2000 Mar;59(3):411-34. Review. Erratum in: Drugs 2002;62(9):1314.

PMID:
10776828
9.

Management of glaucoma: focus on pharmacological therapy.

Marquis RE, Whitson JT.

Drugs Aging. 2005;22(1):1-21. Review.

PMID:
15663346
10.

Controversies in Glaucoma: Current Medical Treatment and Drug Development.

Bucolo C, Platania CB, Reibaldi M, Bonfiglio V, Longo A, Salomone S, Drago F.

Curr Pharm Des. 2015;21(32):4673-81. Review.

PMID:
26350532
11.

[The medical treatment of glaucoma].

Sapir-Pichhadze R, Blumenthal E.

Harefuah. 2003 Jan;142(1):66-9, 76. Review. Hebrew.

PMID:
12647493
12.

Glaucoma medical treatment: philosophy, principles and practice.

Migdal C.

Eye (Lond). 2000 Jun;14 ( Pt 3B):515-8. Review.

PMID:
11026981
13.

New aqueous inflow inhibitors.

Doyle JW, Smith MF.

Semin Ophthalmol. 1999 Sep;14(3):159-63. Review.

PMID:
10790580
14.

Recent advances in the pharmacological treatment of glaucoma.

Razdan RK, Howes JF.

Rev Pure Appl Pharmacol Sci. 1980 Jul-Sep;1(3):183-213. Review. No abstract available.

PMID:
6116262
15.

Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.

Diestelhorst M, Nordmann JP, Toris CB.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S155-61. Review.

PMID:
12204713
16.

Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.

Holló G, Bozkurt B, Irkec M.

Expert Opin Pharmacother. 2009 Aug;10(12):2015-24. doi: 10.1517/14656560903124388. Review.

PMID:
19618994
17.

Glaucoma: a review of adjunctive therapy and new management strategies.

Whitson JT.

Expert Opin Pharmacother. 2007 Dec;8(18):3237-49. Review.

PMID:
18035966
18.

Medical treatment of glaucoma and the promising perspectives.

Diestelhorst M.

Curr Opin Ophthalmol. 1996 Apr;7(2):18-23. Review.

PMID:
10163316
19.

Measurement of aqueous humor flow.

McLaren JW.

Exp Eye Res. 2009 Apr;88(4):641-7. doi: 10.1016/j.exer.2008.10.018. Epub 2008 Nov 6. Review.

PMID:
19026639
20.

New medical therapies for glaucoma.

Drake MV.

Int Ophthalmol Clin. 1996 Spring;36(2):53-60. Review. No abstract available.

PMID:
8950633

Supplemental Content

Support Center